Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.

521 indexed citations
published 2000

Countries where authors are citing Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.

Specialization
Citations

This map shows the geographic impact of Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. more than expected).

Fields of papers citing Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo..

About Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.

This paper, published in 2000, received 521 indexed citations . Written by Lisa M. Butler, David B. Agus, Howard I. Scher, Brian Higgins, Aaron H. Rose, Carlos Cordon‐Cardo, H Thaler, R A Rifkind, P A Marks and Victoria M. Richon covering the research area of Molecular Biology and Oncology. It is primarily cited by scholars working on Molecular Biology (474 citations), Oncology (143 citations) and Pulmonary and Respiratory Medicine (66 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w66418760.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026